AI Article Synopsis

  • * Traditional treatments like chemotherapy and radiotherapy offer limited benefits for these patients, prompting the exploration of alternatives such as iodine-125 seed interstitial brachytherapy.
  • * In 2023, the Chinese College of Interventionalists convened experts to create standardized guidelines for this treatment, covering everything from suitability and preparation to potential complications and follow-up care.

Article Abstract

The incidence of pancreatic cancer is increasing worldwide. Approximately, 60% of patients with pancreatic cancer have distant metastases at the time of diagnosis, of which only 10% can be removed using standard resection. Further, patients derive limited benefits from chemotherapy or radiotherapy. As such, alternative methods to achieve local control have emerged, including permanent iodine-125 seed interstitial brachytherapy. In 2023, the Chinese College of Interventionalists, affiliated with the Chinese Medical Doctor Association, organized a group of multi-disciplinary experts to compose guidelines for this treatment modality. The aim of this conference was to standardize the procedure for permanent iodine-125 seed interstitial brachytherapy, including indications, contraindications, pre-procedural preparation, procedural operations, complications, efficacy evaluation, and follow-up.

Download full-text PDF

Source
http://dx.doi.org/10.4103/jcrt.jcrt_2368_23DOI Listing

Publication Analysis

Top Keywords

permanent iodine-125
12
iodine-125 seed
12
seed interstitial
12
interstitial brachytherapy
12
pancreatic cancer
12
guidelines permanent
4
brachytherapy pancreatic
4
cancer 2023
4
2023 edition
4
edition chinese
4

Similar Publications

Introduction: We report a case of rectal perforation following SpaceOAR placement utilized with iodine-125 low-dose-rate brachytherapy for prostate cancer.

Case Presentation: A 65-year-old patient with localized prostate cancer underwent SpaceOAR placement following LDR-BT. No significant issues occurred with the SpaceOAR procedure, and no abnormalities were found on the next day's T2-weighted magnetic resonance imaging.

View Article and Find Full Text PDF
Article Synopsis
  • * Traditional treatments like chemotherapy and radiotherapy offer limited benefits for these patients, prompting the exploration of alternatives such as iodine-125 seed interstitial brachytherapy.
  • * In 2023, the Chinese College of Interventionalists convened experts to create standardized guidelines for this treatment, covering everything from suitability and preparation to potential complications and follow-up care.
View Article and Find Full Text PDF

Purpose: To quantify changes in prostate size and seed movement over time after transperineal implantation of stranded I seeds, and to determine their impact on prostate dosimetry.

Methods: CT and MR (T2, balanced steady-state free precession) image triplets were acquired on days 0, 3, 10, and 30 for a cohort of 20 patients and registered automatically. Prostate contours were drawn on MR-T2 images; seeds were found and matched in successive CT images.

View Article and Find Full Text PDF

Purpose: To develop an approach to the diagnosis and treatment of prostate cancer using one platform for fusion biopsy, followed by focal gland ablation utilizing permanent prostate brachytherapy with and without a rectal spacer.

Material And Methods: Prostate phantoms containing multiparametric magnetic resonance imaging (mpMRI) regions of interest (ROI) underwent fusion biopsy, followed by image co-registration of positive sites to a treatment planning brachytherapy program. A partial hemi-ablation and both posterior lobes using a Mick applicator and linked stranded seeds were simulated.

View Article and Find Full Text PDF

Side Effects of Permanent Radioactive Iodine-125 Implants Brachytherapy for Prostate Cancer in Nigeria.

West Afr J Med

December 2023

American Radiology Oncology Solutions, Philadelphia, United States of America.

Background: Radioactive seeds implant is a novel option in the developed world for the treatment of organ-confined prostate cancer; however, it is a rare procedure in developing countries, especially in sub-Saharan African countries like Nigeria. The first prostate brachytherapy in Nigeria was performed in 2019 at La'Newton Oncology Clinic using low-dose radioactive iodine-125. The side effects on patients that were treated in three years of its existence in Nigeria are documented in this study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!